Rise in prevalence of structural heart diseases is fueling the structural heart devices market size. The impact of new structural heart interventions and product launches in the field of valve replacement is expected to remain high on the market, globally.
Technological breakthroughs, such as TAVR and hybrid therapy, are likely to provide lucrative structural heart devices market opportunities to vendors. TAVR is a major breakthrough in minimally invasive medical therapy.
Companies with research & development capabilities and technological prowess are estimated to gather momentum and profitability in the structural heart devices industry.
Structural heart procedures may open narrowed heart valves, close holes in the heart, or replace damaged valves. Structural heart devices usually feature vascular closure devices and dual-lumen catheters.
These devices can be implanted through a minimally invasive approach. They are employed in the treatment and management of structural heart diseases including aortic valve disease, atrial septal defect, ventricular septal defect, hypertrophic cardiomyopathy, mitral valve disease, and tricuspid and pulmonic valve disease.
Demand for structural heart devices has seen a paradigm shift with the advent of non-invasive procedures to treat aortic stenosis and mitral regurgitation. Surge in investment in minimally-invasive heart valve technologies is expected to spur the structural heart devices market growth in the near future.
| Attribute | Detail |
|---|---|
| Drivers |
|
Structural heart diseases affect the valves, walls, chambers, or muscles of the heart. These diseases include aortic valve disease, atrial septal defect, and ventricular septal defect. The prevalence of structural heart disease is high among newborns.
Heart valve disease is the most common type of structural heart disease. It affects about 2.5% of all people in the U.S. More than 2 million people in the country have a leaky heart valve. Additionally, about 1.4 million adults and 1 million children in the U.S. have a congenital heart condition.
Surge in adoption of minimally invasive devices is driving the structural heart devices market development. Minimally invasive approaches can be used for structural heart disease treatment.
These approaches help avoid opening the chest and breastbone. A flexible, hollow tube (catheter) is employed to access the heart through a blood vessel in the groin.
In October 2023, Abbott announced data from the TRILUMINATE pivotal trial that reinforced the safety and effectiveness of the TriClip transcatheter edge-to-edge repair (TEER) system for patients with symptomatic, severe tricuspid regurgitation despite optimal medical therapy.
Hence, R&D in minimally invasive heart devices in the treatment of mitral and tricuspid valve disease is propelling the market expansion.
Structural heart devices are common in newborn babies. For example, an atrial septal defect is a birth defect of the heart in which there is a hole in the wall (septum) that divides the upper chambers (atria) of the heart.
Atrial septal defect has a birth prevalence of 2.5/1000 live births, 25% to 30% of which are present in adulthood. Thus, rise in prevalence of atrial septal defects is boosting the structural heart devices market trajectory.
In January 2024, Occlutech, a Swedish medical device company focused on structural heart disease, received U.S. Food and Drug Administration (FDA) approval for its ASD Occluder for the treatment of atrial septal defects.
The company also gained FDA approval for its Pistol Pusher delivery system, and the two offerings will be commercialized throughout the U.S. as part of an exclusive arrangement with B. Braun Interventional Systems. Hence, approval and launch of new devices is augmenting the structural heart devices market statistics.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
According to the latest structural heart devices market insights, North America held largest share in 2022. R&D of new products is propelling the market dynamics of the region.
In July 2023, CardioPrecision entered the U.S. market with the introduction of its technology for use in Endoscopic Vessel Harvesting (EVH) during coronary artery bypass grafting (CABG) surgery at the Massachusetts General Hospital in Boston.
The Glasgow-based company is focused on less invasive treatment of structural heart disease.
Surge in awareness about structural heart diseases and favorable reimbursement policies for devices are also boosting the structural heart devices market share in North America.
Several public and privately held organizations are conducting awareness programs highlighting the risk factors, symptoms, diagnosis, and treatment options for valvular heart disease and other heart defects.
Major players are focused on the design, manufacture, and commercialization of disruptive catheter-based technologies for the treatment of structural heart disease.
The structural heart devices market landscape is highly consolidated, with the presence of major players including Medtronic, Abbott, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova plc, Lepu Medical, Micro Interventional Devices, Inc., LifeTech Scientific Corporation, and CryoLife, Inc.
These companies have been profiled in the structural heart devices market report based on various parameters including company overview, business segments, product portfolio, recent developments, business strategies, and financial overview.
| Attribute | Detail |
|---|---|
| Market Size in 2022 | US$ 11.9 Bn |
| Market Forecast (Value) in 2031 | US$ 20.5 Bn |
| Growth Rate (CAGR) | 6.5% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Tons | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 11.9 Bn in 2022
It is anticipated to grow at a CAGR of 6.5% from 2023 to 2031
Rise in prevalence of structural heart diseases and approval and launch of new devices
North America was the leading region in 2022
Medtronic, Abbott, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova plc, Lepu Medical, Micro Interventional Devices, Inc., LifeTech Scientific Corporation, and CryoLife, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Structural Heart Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Structural Heart Devices Market Analysis and Forecast, 2017-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Structural Heart Devices Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017-2031
6.3.1. Biological/Tissue Valves
6.3.1.1. Transcatheter Heart Valves
6.3.1.2. Surgical Heart Valves
6.3.2. Mechanical Heart Valves
6.3.3. Annuloplasty Rings
6.3.4. Occluders
6.3.5. Accessories
6.4. Market Attractiveness Analysis, by Product
7. Global Structural Heart Devices Market Analysis and Forecast, by Procedure
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Procedure, 2017-2031
7.3.1. Replacement Procedures
7.3.2. Repair Procedures
7.4. Market Attractiveness Analysis, by Procedure
8. Global Structural Heart Devices Market Analysis and Forecast, by Indication
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Indication, 2017-2031
8.3.1. Valve Stenosis
8.3.2. Valve Regurgitation
8.3.3. Cardiomyopathy
8.3.4. Congenital Heart Defects
8.3.5. Others
8.4. Market Attractiveness Analysis, by Indication
9. Global Structural Heart Devices Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017-2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Structural Heart Devices Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product, 2017-2031
10.3.1. Biological/Tissue Valves
10.3.1.1. Transcatheter Heart Valves
10.3.1.2. Surgical Heart Valves
10.3.2. Mechanical Heart Valves
10.3.3. Annuloplasty Rings
10.3.4. Occluders
10.3.5. Accessories
10.4. Market Value Forecast, by Procedure, 2017-2031
10.4.1. Replacement Procedures
10.4.2. Repair Procedures
10.5. Market Value Forecast, by Indication, 2017-2031
10.5.1. Valve Stenosis
10.5.2. Valve Regurgitation
10.5.3. Cardiomyopathy
10.5.4. Congenital Heart Defects
10.5.5. Others
10.6. Market Value Forecast, by Country, 2017-2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product
10.7.2. By Procedure
10.7.3. By Indication
10.7.4. By Country
11. Europe Structural Heart Devices Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product, 2017-2031
11.3.1. Biological/Tissue Valves
11.3.1.1. Transcatheter Heart Valves
11.3.1.2. Surgical Heart Valves
11.3.2. Mechanical Heart Valves
11.3.3. Annuloplasty Rings
11.3.4. Occluders
11.3.5. Accessories
11.4. Market Value Forecast, by Procedure, 2017-2031
11.4.1. Replacement Procedures
11.4.2. Repair Procedures
11.5. Market Value Forecast, by Indication, 2017-2031
11.5.1. Valve Stenosis
11.5.2. Valve Regurgitation
11.5.3. Cardiomyopathy
11.5.4. Congenital Heart Defects
11.5.5. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Procedure
11.7.3. By Indication
11.7.4. By Country/Sub-region
12. Asia Pacific Structural Heart Devices Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product, 2017-2031
12.3.1. Biological/Tissue Valves
12.3.1.1. Transcatheter Heart Valves
12.3.1.2. Surgical Heart Valves
12.3.2. Mechanical Heart Valves
12.3.3. Annuloplasty Rings
12.3.4. Occluders
12.3.5. Accessories
12.4. Market Value Forecast, by Procedure, 2017-2031
12.4.1. Replacement Procedures
12.4.2. Repair Procedures
12.5. Market Value Forecast, by Indication, 2017-2031
12.5.1. Valve Stenosis
12.5.2. Valve Regurgitation
12.5.3. Cardiomyopathy
12.5.4. Congenital Heart Defects
12.5.5. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Procedure
12.7.3. By Indication
12.7.4. By Country/Sub-region
13. Latin America Structural Heart Devices Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product, 2017-2031
13.3.1. Biological/Tissue Valves
13.3.1.1. Transcatheter Heart Valves
13.3.1.2. Surgical Heart Valves
13.3.2. Mechanical Heart Valves
13.3.3. Annuloplasty Rings
13.3.4. Occluders
13.3.5. Accessories
13.4. Market Value Forecast, by Procedure, 2017-2031
13.4.1. Replacement Procedures
13.4.2. Repair Procedures
13.5. Market Value Forecast, by Indication, 2017-2031
13.5.1. Valve Stenosis
13.5.2. Valve Regurgitation
13.5.3. Cardiomyopathy
13.5.4. Congenital Heart Defects
13.5.5. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Procedure
13.7.3. By Indication
13.7.4. By Country/Sub-region
14. Middle East & Africa Structural Heart Devices Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product, 2017-2031
14.3.1. Biological/Tissue Valves
14.3.1.1. Transcatheter Heart Valves
14.3.1.2. Surgical Heart Valves
14.3.2. Mechanical Heart Valves
14.3.3. Annuloplasty Rings
14.3.4. Occluders
14.3.5. Accessories
14.4. Market Value Forecast, by Procedure, 2017-2031
14.4.1. Replacement Procedures
14.4.2. Repair Procedures
14.5. Market Value Forecast, by Indication, 2017-2031
14.5.1. Valve Stenosis
14.5.2. Valve Regurgitation
14.5.3. Cardiomyopathy
14.5.4. Congenital Heart Defects
14.5.5. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Procedure
14.7.3. By Indication
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Medtronic
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Abbott
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Boston Scientific Corporation
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Edwards Lifesciences Corporation
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. LivaNova plc
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Lepu Medical
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Micro Interventional Devices, Inc.
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. LifeTech Scientific Corporation
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. CryoLife, Inc.
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
List of Tables
Table 01: Global Structural Heart Devices Market Size (US$ Mn) Forecast, by Product, 2017-2031
Table 02: Global Structural Heart Devices Market Size (US$ Mn) Forecast, by Procedure, 2017-2031
Table 03: Global Structural Heart Devices Market Size (US$ Mn) Forecast, by Indication, 2017-2031
Table 04: Global Structural Heart Devices Market Size (US$ Mn) Forecast, by Region, 2017-2031
Table 05: North America Structural Heart Devices Market Size (US$ Mn) Forecast, by Country, 2017-2031
Table 06: North America Structural Heart Devices Market Size (US$ Mn) Forecast, by Product, 2017-2031
Table 07: North America Structural Heart Devices Market Size (US$ Mn) Forecast, by Procedure, 2017-2031
Table 08: North America Structural Heart Devices Market Size (US$ Mn) Forecast, by Indication, 2017-2031
Table 09: Europe Structural Heart Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 10: Europe Structural Heart Devices Market Size (US$ Mn) Forecast, by Product, 2017-2031
Table 11: Europe Structural Heart Devices Market Size (US$ Mn) Forecast, by Procedure, 2017-2031
Table 12: Europe Structural Heart Devices Market Size (US$ Mn) Forecast, by Indication, 2017-2031
Table 13: Asia Pacific Structural Heart Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 14: Asia Pacific Structural Heart Devices Market Size (US$ Mn) Forecast, by Product, 2017-2031
Table 15: Asia Pacific Structural Heart Devices Market Size (US$ Mn) Forecast, by Procedure, 2017-2031
Table 16: Asia Pacific Structural Heart Devices Market Size (US$ Mn) Forecast, by Indication, 2017-2031
Table 17: Latin America Structural Heart Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 18: Latin America Structural Heart Devices Market Size (US$ Mn) Forecast, by Product, 2017-2031
Table 19: Latin America Structural Heart Devices Market Size (US$ Mn) Forecast, by Procedure, 2017-2031
Table 20: Latin America Structural Heart Devices Market Size (US$ Mn) Forecast, by Indication, 2017-2031
Table 21: Middle East & Africa Structural Heart Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Middle East & Africa Structural Heart Devices Market Size (US$ Mn) Forecast, by Product, 2017-2031
Table 23: Middle East & Africa Structural Heart Devices Market Size (US$ Mn) Forecast, by Procedure, 2017-2031
Table 24: Middle East & Africa Structural Heart Devices Market Size (US$ Mn) Forecast, by Indication, 2017-2031
List of Figures
Figure 01: Global Structural Heart Devices Market Size (US$ Mn) and Distribution (%), by Region, 2022 and 2031
Figure 02: Global Structural Heart Devices Market Revenue (US$ Mn), by Product, 2022
Figure 03: Global Structural Heart Devices Market Value Share, by Product, 2022
Figure 04: Global Structural Heart Devices Market Revenue (US$ Mn), by Procedure, 2022
Figure 05: Global Structural Heart Devices Market Value Share, by Procedure, 2022
Figure 06: Global Structural Heart Devices Market Revenue (US$ Mn), by Indication, 2022
Figure 07: Global Structural Heart Devices Market Value Share, by Indication, 2022
Figure 08: Global Structural Heart Devices Market Value Share, by Region, 2022
Figure 09: Global Structural Heart Devices Market Value (US$ Mn) Forecast, 2017-2031
Figure 10: Global Structural Heart Devices Market Value Share Analysis, by Product, 2022 and 2031
Figure 11: Global Structural Heart Devices Market Attractiveness Analysis, by Product, 2023-2031
Figure 12: Global Structural Heart Devices Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 13: Global Structural Heart Devices Market Attractiveness Analysis, by Procedure, 2023-2031
Figure 14: Global Structural Heart Devices Market Value Share Analysis, by Indication, 2022 and 2031
Figure 15: Global Structural Heart Devices Market Attractiveness Analysis, by Indication, 2023-2031
Figure 16: Global Structural Heart Devices Market Value Share Analysis, by Region, 2022 and 2031
Figure 17: Global Structural Heart Devices Market Attractiveness Analysis, by Region, 2023-2031
Figure 18: North America Structural Heart Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 19: North America Structural Heart Devices Market Attractiveness Analysis, by Country, 2023-2031
Figure 20: North America Structural Heart Devices Market Value Share Analysis, by Country, 2022 and 2031
Figure 21: North America Structural Heart Devices Market Value Share Analysis, by Product, 2022 and 2031
Figure 22: North America Structural Heart Devices Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 23: North America Structural Heart Devices Market Value Share Analysis, by Indication, 2022 and 2031
Figure 24: North America Structural Heart Devices Market Attractiveness Analysis, by Product, 2023-2031
Figure 25: North America Structural Heart Devices Market Attractiveness Analysis, by Procedure, 2023-2031
Figure 26: North America Structural Heart Devices Market Attractiveness Analysis, by Indication, 2023-2031
Figure 27: Europe Structural Heart Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 28: Europe Structural Heart Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 29: Europe Structural Heart Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 30: Europe Structural Heart Devices Market Value Share Analysis, by Product, 2022 and 2031
Figure 31: Europe Structural Heart Devices Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 32: Europe Structural Heart Devices Market Value Share Analysis, by Indication, 2022 and 2031
Figure 33: Europe Structural Heart Devices Market Attractiveness Analysis, by Product, 2023-2031
Figure 34: Europe Structural Heart Devices Market Attractiveness Analysis, by Procedure, 2023-2031
Figure 35: Europe Structural Heart Devices Market Attractiveness Analysis, by Indication, 2023-2031
Figure 36: Asia Pacific Structural Heart Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 37: Asia Pacific Structural Heart Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 38: Asia Pacific Structural Heart Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 39: Asia Pacific Structural Heart Devices Market Value Share Analysis, by Product, 2022 and 2031
Figure 40: Asia Pacific Structural Heart Devices Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 41: Asia Pacific Structural Heart Devices Market Value Share Analysis, by Indication, 2022 and 2031
Figure 42: Asia Pacific Structural Heart Devices Market Attractiveness Analysis, by Product, 2023-2031
Figure 43: Asia Pacific Structural Heart Devices Market Attractiveness Analysis, by Procedure, 2023-2031
Figure 44: Asia Pacific Structural Heart Devices Market Attractiveness Analysis, by Indication, 2023-2031
Figure 45: Latin America Structural Heart Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 46: Latin America Structural Heart Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 47: Latin America Structural Heart Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 48: Latin America Structural Heart Devices Market Value Share Analysis, by Product, 2022 and 2031
Figure 49: Latin America Structural Heart Devices Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 50: Latin America Structural Heart Devices Market Value Share Analysis, by Indication, 2022 and 2031
Figure 51: Latin America Structural Heart Devices Market Attractiveness Analysis, by Product, 2023-2031
Figure 52: Latin America Structural Heart Devices Market Attractiveness Analysis, by Procedure, 2023-2031
Figure 53: Latin America Structural Heart Devices Market Attractiveness Analysis, by Indication, 2023-2031
Figure 54: Middle East & Africa Structural Heart Devices Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 55: Middle East & Africa Structural Heart Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 56: Middle East & Africa Structural Heart Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 57: Middle East & Africa Structural Heart Devices Market Value Share Analysis, by Product, 2022 and 2031
Figure 58: Middle East & Africa Structural Heart Devices Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 59: Middle East & Africa Structural Heart Devices Market Value Share Analysis, by Indication, 2022 and 2031
Figure 60: Middle East & Africa Structural Heart Devices Market Attractiveness Analysis, by Product, 2023-2031
Figure 61: Middle East & Africa Structural Heart Devices Market Attractiveness Analysis, by Procedure, 2023-2031
Figure 62: Middle East & Africa Structural Heart Devices Market Attractiveness Analysis, by Indication, 2023-2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Structural Heart Devices Market
